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Abstract 
BACKGROUND: The gathered archeopathological evidence has confirmed that Schistosomiasis has been 
endemic in Ancient Egypt for over 500 decades. The association between Schistosoma hematobium and increase 
bladder cancer risk is also well acknowledged. However, over the years, there is a proved changing pattern of 
bladder cancer that needs to be investigated.  
AIM: We aim to discuss the truths and myths about bladder cancer and its association with Schistosomiasis in 
Egypt.  
METHODS: A cross-sectional, case-control study was performed to collect recent data on the topic. 
RESULTS: Of the reported cancer cases, 79.3% were transitional cell carcinoma (TCC), an additional 6% 
showed associated squamous features. Squamous cell carcinoma (SCC) constituted only 13.8% of cancer cases. 
Schistosomiasis was histologically confirmed in 19 cancer cases, only one was SCC. The relative frequency of 
TCC is increasing, while SCC is decreasing. There is no evidence that this pattern is related to smoking or 
environmental factors, as the incidence of lung cancer, is not proportionately increasing. 
CONCLUSION: The old concept that Schistosomiasis is associated with SCC should be revaluated as most 
cases are associated with TCC. Relying on the histopathology for confirmation of Schistosomiasis in our research 
studies appears to be non-accurate and leads to irrelevant results. 
 
 
 
 
Introduction 
 
Schistosomiasis is an ancient disease, 
depicted in papyri from Pharaonic Egypt, not less than 
50 times, including Ebers: 28, Berlin: 12, Hearst: 9, 
and London: 1. The classic symptom of blood in the 
urine has been described in the Ebers papyrus as the 
āāā disease and has been mentioned in various other 
medical papyri that contained prescriptions against 
hematuria [1], [2]. Later evidence of Schistosomiasis 
in medieval Egypt was detected in 15 mummies from 
35 to 550 AD in the Wadi Halfa near the Egypt-Sudan 
border [3]. 
Nowadays, Schistosomiasis is the second 
most common parasite affecting humans. In 2015, 
WHO reported Schistosomiasis as endemic in 78 
countries; with Africa being the most affected as it has 
been reported in 42 African countries [4]. 
Ferguson (1911) had first linked S. 
hematobium to urinary bladder cancer in Egypt [5]. In 
1994 and 2012, IARC (International Agency for 
Research on Cancer) confirmed that chronic 
infestation by S. hematobium is associated with 
cancer of the urinary bladder [6], [7]. Since then, the 
association between S. hematobium and cancer 
bladder has become well established [8], [15]. Urinary 
bladder cancer is the second common cancer among 
males (≈ 12.7%) following HCC as reported by results 
of the National Population-Based Cancer Registry 
Program in Egypt, 2014 as well as GLOBOCAN, 2018 
[16], [17]. In his report, Ghoneim et al. (1997) declared 
that squamous cell carcinoma (SCC) constituted 59% 
of 1026 cystectomy specimens at the Mansoura 
Urology and Nephrology Centre [18]. 
Most of the research studies in this field have 
confirmed the epidemiological association between 
SCC of the bladder with S. hematobia. SCC was 
documented as prevalent in areas with high worm 
burdens whereas TCC was more commonly reported 
in areas associated with lower degrees of infestation. 
TCC risk was attributed to the continuous exposure to 
the carcinogens, e.g., N-nitroso compounds [19], [20]. 
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However, these compounds were presumably 
detected in larger quantities in the urine of patients 
with S. hematobium than in patients without this 
infection [21], [22]. 
Nowadays, there is a growing belief that the 
control of Schistosomiasis in Egypt has led to a 
change in the type of bladder cancers with a continual 
decrease of SCC and subsequent increase of 
Urothelial tumours [22], [23]. Felix et al., (2008) 
reviewed the reports of 2,778 patients through 26 
years and concluded that there is a decline in the rate 
of SCC associated with an increasing rate of TCC 
[24]. Other studies claimed a drop in the frequency 
rate of bladder cancer related to the successful control 
of Schistosomiasis [25], [28]. Worth mentioning, some 
research studies have omitted S. hematobium from 
epidemiology and bladder cancer prevention [29]. 
More research is needed to investigate this 
changing pattern of bladder cancer in Egypt and to 
find out an answer to the following questions: “Why is 
the rate of bladder cancer still high in Egypt in spite of 
the claim of Schistosomiasis control?”, “Is the S. 
hematobium related to SCC rather than TCC?”, “Do 
we have an accurate reporting of the actual 
Schistosomiasis burden in Egypt?”, and “What are the 
possible national measures that could be 
implemented to control such preventable cancer?” 
[30], [31]. 
We aim to investigate and to refute the beliefs 
about urinary bladder cancer in Egypt. There are 
questions to be answered and claims to be judged. 
 
 
Material and Methods 
 
Case Selection & histopathological study 
Design: In this case-control, observational 
study, 116 consecutive samples from bladder 
masses-from the authors’ practice in six-month 
duration-were compiled and reviewed. The samples 
included neoplastic and non-neoplastic cases. It was 
noted that five of which were referred twice (i.e. 111 
patients). A detailed evaluation of the available data 
was presented and analysed. Data including age, sex, 
type of specimen, type of lesion, grade and stage of 
carcinoma and associated S. hematobium infestation 
was examined, reported, evaluated and discussed. 
 
Statistical analysis 
Data were coded and entered using the 
statistical package SPSS (Statistical Package for the 
Social Sciences) version 25. Data were summarised 
using mean, standard deviation, minimum and 
maximum in quantitative data and using 
frequency/count and relative frequency/percentage for 
categorical data. Chi-square (2) test was performed 
for comparing categorical data. The exact test was 
used when the frequency is less than 5. P-values less 
than 0.05 were considered statistically significant [32]. 
 
 
Results 
 
The results are summarised in the Tables (1, 
2 and 3). 
 
Figure 1: Relation between cancer type and Schistosoma 
infestation (Positive for S. Hematobium; Features of 
Schistosomiasis = Proliferative cystitis with Brunn’s nests, cystitis 
cystica and cystitis glandularis; Negative = no identifiable ova or 
proliferative lesions) 
 
 Out of the 116 samples, 93 belonged to males 
(81%). Eighty-seven (75%) specimens were 
diagnosed as cancer bladder. 
Table 1: Frequency and percentage table of bladder cancer 
cases 
  Count % 
Total Total 116 100.0% 
Group Cancer either by biopsy or cystectomy 87 75.0% 
sex 
Male 77 85.5% 
Female 10 14.5% 
 
Specimen 
TURBT 98 84.5% 
Cystectomy 18 15.5% 
 
 Positive 28 24.1% 
Schistosomi
asis 
Features suggestive 19 16.4% 
 Not documented 69 59.5% 
 I 11 12.6% 
 I-II 14 16.1% 
 II 24 27.6% 
 II-III 15 17.2% 
 III 23 26.4% 
 Signet ring carcinoma 1 1% 
Grade 
Adenocarcinoma 2 2% 
Papillary TCC 28 32% 
 
 Recurrent TCC/adenocarcinoma 1 1% 
 Recurrent TCC 2 2% 
 TCC 36 41.4% 
 TCC/SCC 5 5.7% 
 SCC 12 13.8% 
 Ta 21 24.1% 
 T1 17 19.5% 
 T2a 4 4.6% 
 T2b 32 36.8% 
 T3a 1 1.1% 
Stage 
T3b 7 8.0% 
T4a 2 2.3% 
 
 T4 (enteric invasion) 1 1.1% 
 T4 (prostatic invasion) 1 1.1% 
 Tx 1 1.1% 
 N0 13 14.9% 
 
N2 3 3.4% 
LN 
No nodes 71 81.6% 
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Twenty-nine had inflammatory mass lesions; 
one of which presented by a few months later by 
cancer. A wide age range (20-78 years)-mean 61.56-
was noted in the neoplastic lesions, and (13-76 
years)-mean 47-in inflammatory lesions (Table 2). 
Table 2: Frequency and percentage table of cystitis 
  Count % 
 Non-specific cystitis 9 31% 
 With Suspected But Not Definitely Diagnosed 
Schistosomiasis 
11 38% 
 
 
 Schisosomial cystitis cases 9 31% 
Total Total 29 100.0% 
Sex M 22 74.9% 
F 7 24.1% 
 
 Active Schistosomiasis 5 4.5% 
 Old Schistosomiasis 4 1.8% 
 Giant cell cystitis 1 0.9% 
 Non-specific cystitis 2 3.6% 
Type 
Proliferative cystitis 5 4.5% 
 
 Proliferative cystitis/dysplsia 1 0.9% 
 Proliferative cystitis/squamous metaplasia 3 2.7% 
 ulcer 3 2.7% 
 
Regarding the cancer cases, 77 samples from 
74 patients (85.5%) were males, and only 10 were 
females. Sixty-nine samples were TURBT while 18 
were radical cystectomy specimens. A total of 69 
cases (79.3%) were transitional cell carcinoma (TCC). 
Thirty-eight cases (43.7%) were invasive TCC ( two of 
which were recurrent), 22 cases (25%) were 
superficial non-invasive low- grade papillary TCC, 6 
cases (7%) were invasive papillary TCC, Five cases 
(6%) showed associated squamous features, and only 
one case (< 1%) showed associated adenocarcinoma 
features. Only 12 cases (13.8%) were pure squamous 
cell carcinoma (SCC). Three cases (3.5%) were pure 
adenocarcinoma. No neuroendocrine features were 
reported in any lesion [33] (Table 1). 
Worth mentioning, one case-diagnosed as 
superficial non-invasive low-grade papillary TCC- 
presented 9 months later by invasive squamous cell 
carcinoma grade 2 associated with positive lamina 
propria invasion (Figure 2A and 2B). 
 
Figure 2: Microscopic picture of frequently reported bladder cancers 
 
Regarding the stage, 21 cases were Ta, 17 
cases were T1, 36 cases were T2, and 8 cases were 
T3, and 4 cases were T4. As regards nodal status, 13 
cases were N0, and 3 cases were N2. 
Schistosomiasis was histologically confirmed 
in 19 cases (Figure 2C and 2D), only three were SCC. 
Features suggestive for schistosomiasis were noted in 
8 cases (proliferative cystitis with/without squamous 
metaplasia). Hematobia ova were not detected 
histologically in 60 cases (Table 3). 
Table 3: Differential Frequency and percentage of bladder 
cancer types 
  
   Cancer Type     
Adenocarcinoma SCC TCC TCC/SCC P value 
Count % Count % Count % Count %  
Schistosomiasis 
Positive 1 33.3% 3 25.0% 12 17.9% 3 60.0%  
Features 0 0.0% 0 0.0% 7 10.4% 1 20.0% 
0.149 
Negative 2 66.7% 9 75.0% 48 71.6% 1 20.0% 
 
 Total 3 100.00% 12 
100.00
% 
67 
100.00
% 
5 100.00% 
 
 
 
In inflammatory mass lesions, Schistosoma 
ova were histologically detected in only 9 cases 
(Figure 2E]. 
 
 
Discussion 
 
Although the sample size is small, it reflects 
the current condition in Egypt. 
The male to female prevalence worldwide is 
reported to be 3: 1 [17], [31]. The ratio is slightly 
higher in our reports, as males represent 85.5% of the 
reported cancer samples. Several molecular studies 
suggested a role of loss of Y-chromosome [34], [35]. 
The mean age for cancer is reported to be 
61.56, following the inflammatory lesions by about 15 
years-mean age being 47 years. This suggests a 
chronic inflammatory process preceding the cancer. 
As regards the type of cancer and its relation 
to Schistosomiasis the following issues are to be 
discussed: 
 
Myth 1: Schistosomiasis is associated with 
 SCC 
SCC is thought to be associated with S. 
Hematobum and is very rare in individuals/areas free 
of the parasite. The reported SCC incidence rate is 
10: 1,000 in infected adults, but only in 0-3: 1,000 
schistosome-free individuals [20], [36]. 
Truth: On applying similar research 
methodology that depends on the histologic 
confirmation of the parasitic infestation; S. 
Hematobium was histologically confirmed in only three 
SCC cases, representing a non-significant correlation. 
Only 3 cases of pure SCC carcinoma showed 
S. Hematobium ova, nine showed no histologic proof 
of infestation. Cases of mixed TCC/SCC showed ova 
in three out of five. One case showed associated 
Brunn’s nests and one did not even show any 
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associated proliferative lesion. 
The association of Schistosoma associated 
SCC as compared to other types of bladder cancer 
represents a non-significant relation (p-value is 
0.355). The correlation is also non-significant in 
comparing SCC with TCC (p-value is 0.8). 
We do not deny the construct that SCC is 
strongly associated with S. Hematobium. However, 
we predict that nowadays, Schistosomiasis is more 
consistently related to TCC. 
In our records, a case that was diagnosed as 
bilharzial cystitis has presented nine months later by 
muscle-invasive high-grade TCC (Figure 2D and 2E). 
We conjointly believe that in all the reported 
research studies; including our present study; we 
have a major flaw within the scientific methodology. 
That is relying on the histopathologic assessment for 
the diagnosis of Schistosomiasis [22]. 
In our records, a case with submitted 
recurrent lesion showed S. Hematobia ova in the latter 
specimen that was not detected within the former 
biopsy. 
We need more accurate laboratory methods 
of confirmation of the parasitic infestation. However, 
the firm belief of the oncologists that the lines of 
management are similar whether there is associated 
infestation or not hinders conducting such laboratory 
investigations and also limits their use in the research 
field [22]. 
 
Myth 2: SCC is prevalent in rural Africa as 
 the parasite is prevalent 
The epidemiological association between 
SCC of the bladder with S. Hematobia is based both 
on case-control studies and on the correlation of 
bladder cancer incidence with the prevalence of S. 
Hematobium infection within the diverse geographic 
areas [10], [32]. 
Truth: In Egypt, bladder cancer is the second 
common cancer in males. However, the 
predominating type is TCC (86%), not SCC. 86% of 
our collected cases were TCC, 18% showed 
histopathologic evidence of S. Hematobium 
infestation. This is also confirmed by studies done on 
larger cohorts [20], [23]. 
 
Myth 3: Schistosomiasis is associated with 
 poorly differentiated SCC 
Schistosoma-associated cancer usually 
present as poorly differentiated squamous cell 
carcinoma [11], [37]. 
Truth: In our study, only two of the twelve 
collected cases were poorly differentiated; the others 
were grades I and II. Cases of TCC/SCC were high-
grade tumours. 
In our records, one case with superficial non-
invasive papillary TCC presented eight months later 
by muscle-invasive SCC, grade 2. Schistosomiasis 
was not detected in either lesion. 
 
Myth 4: Schistosomiasis associated 
 bladder SCC presents relatively early 
Schistosomiasis -associated bladder SCC 
appears relatively early, especially due to re-infection. 
It often presents at the mid-decades of life. TCC 
usually presents in the latter decades of life [37]. 
Truth: According to our collected data, the 
mean age for SCC presentation was 60.58 (36-78 
years), and for TCC was 61.5 (20-78 years). The 
mean age of presentation is nearly similar. 
 
Myth 5: Successful control of 
 Schistosomiasis has led to changing the 
 pattern of bladder cancer 
The decline in the incidence of SCC in Egypt 
is attributed to the successful control of 
Schistosomiasis [28]. Thus the pattern is changing in 
Egypt approaching that of the regions not endemic for 
urogenital schistosomiasis is TCC [11], [37]. 
Truth: In our reported cases the ova were 
histologically detected in 12 cases of the TCC and 
only 3 of the SCC. The correlation is insignificant for 
both. However, it is more associated with TCC. 
Twenty-two cases (25%) were superficial non-invasive 
low-grade papillary TCC, all of which showed no S. 
hematobium ova in tissue sections. 
Here we should confess that the histological 
evaluation of Schistosomial infestation is not precise. 
Unfortunately, most of the research work in this field 
does not depend on the modern techniques for 
evaluation of Schistosomal infestation and depends 
on the histopathologic findings, which proved to be 
inaccurate. 
For accurate assessment of the condition, we 
should depend on urine examination and/or 
serological methods [36]. 
 
Myth 6: Increased smoking and exposure 
 to pesticides has led to an increased 
 incidence of TCC 
It is claimed that smoking, including passive 
smoking as well as exposure to environmental 
hazards, has contributed to the increased incidence of 
TCC [28]. Recent research studies suggest that 
tobacco smoking increases the risk of bladder 
carcinoma in Egyptian men [39], [40]. 
Truth: This postulation is not supported by the 
results of the national registry, as there is no 
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associated increased incidence of lung cancer, 
especially in males. According to the registry in 2014, 
the bladder is the second common cancer in men 
while the lung is the fourth malignancy, after liver, 
bladder, and Hodgkin lymphoma, representing only 
(8.2%) of the reported malignancies. If smoking is a 
major risk factor for the increasing TCC in Egypt, a 
proportionate increase in lung cancer should have 
been expected. Moreover, the Schistosomiasis in 
bladder cancer patients should be confirmed or 
excluded by using the hemagglutinin and/or urine 
tests before postulating that the increased rate of TCC 
is attributed to smoking. 
More research is needed in the field of the 
molecular basis of bladder cancer in Egypt as the 
available knowledge is deficient in this field [41], [42]. 
 
Myth 7: Treatment strategies have similar 
 end-results regardless of etiologic 
 factor(s) implicated in bladder 
 carcinogenesis [22] 
There is a solid belief that the management of 
Schistosoma-associated bladder cancer should follow 
the recommendations for the Schistosoma non-
associated urothelial cancers. This belief is one of the 
main reasons for intentionally or non-intentionally 
omitting the reporting of associated infestation in our 
cancer cases. Subsequently, no treatment strategy is 
directed towards eliminating the infestation in cancer 
patients. 
Truth: It is well known for decades that nodal 
metastasis is rare in our bladder cancer patients; even 
with the advanced stage at presentation. In our study, 
only three cases were reported with nodal metastasis 
(none has shown associated ova). This was 
previously attributed to the high frequency of low-
grade tumours and/or the limiting effect of local 
Schistosomal tissue reactions [43]. 
However, we need more molecular studies to 
validate these beliefs, as we have an increased rate of 
higher grade tumours (> 50% of our reported cases 
were high-grade TCC), with no associated increased 
rate of nodal metastasis. Such studies will surely have 
a great impact on treatment strategies to avoid 
overtreatment. 
 
Limitations of previous research studies in 
 Egypt 
- Felix et al. in their records of cancer bladder 
in the period from 1980 through 2005 at the National 
Cancer Institute (NCI) from 1980 through 2005 
admitted that reporting of Schistosomiasis was 
missing in some of the records due to the assumption 
that it would not affect the course of treatment [25]. 
- Bladder cancers were classified as 
Schistosoma associated and non-Schistosoma 
associated based on the history of Schistosomal 
infection, ever receiving anti-Schistosomal therapy, 
presence of periportal fibrosis on ultrasound liver 
examination, or presence of Schistosome ova in the 
tumour specimen [21], [22], [23]. None of these is 
considered to be accurate in confirmation or ruling out 
of the infestation. 
- No antecedently published work has 
investigated the possibility of underestimation of 
Schistosomal infestation. 
- The studies on the molecular basis of 
bladder cancer in Egypt and its changing patterns are 
limited [44], [45], [46], [47], [48], [49], [50]. 
- We need more research work on non-
invasive techniques for the early detection of the 
parasitic infestation and early cancer detection of 
susceptible individuals [51]. 
- Adoptive immunotherapy offers promise in 
cancer treatment. Further research is necessary to 
bring immunotherapy further to the forefront of treating 
bladder cancer [53]. 
 We can conclude that: 
1. Bladder cancer is the 2
nd
 common cancer 
among males in Egypt, the 6th worldwide. The 4th 
cumulatively in Egypt and the 10
th
 globally. 
2. Bladder cancer remains a major health 
problem in Egypt in spite of the evidence of 
Schistosomiasis control. 
3. There is evidence that the types and 
patterns of bladder cancer are changing in Egypt. 
4. The increased rate of TCC could not be 
attributed to smoking only. As there is no associated 
increase in lung cancers among Egyptian men. 
5. Preventing Schistosomiasis (successful 
eradication programs) is the best treatment and least 
expensive way of fighting bladder cancer in endemic 
areas. 
6. Unfortunately, most of the research work in 
the field does not depend on sensitive techniques for 
the detection of Schistosoma infestation and depends 
on the histopathologic findings which have proved to 
be inaccurate. The worse is that the recently published 
articles declare that, upon applying the same 
treatment protocol and management care, stage by 
stage comparison of the treatment end-results was 
found to be similar in bladder cancer patients with a 
different aetiology. 
7. More research study on the molecular 
basis of Schistosomiasis-TCC associated cancer in 
urine, serology and mouse bladder wall injection 
model is needed to understand the changing pattern 
of bladder cancer. 
8. Leading policymakers should be 
acquainted with this data to be able to adopt a 
national screening program for Schistosomiasis, 
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similar to the successful model of HCV control. The 
implementation of evidence-based measures in 
bladder cancer control may decrease the burden of 
this cancer in Egypt. 
9. The availability of a large number of 
patients will allow the review of old concepts and 
better evaluation of the present condition. 
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